ICUI up +14.54% percent right now. $ICUI High is at 87.50

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 12:19 PM

ICUI up +14.54% percent right now. $ICUI High is at 87.50 and the Low 80.15 with current volume of 540,314.

Recent News posted below.

ICUI Icu Medical Recent Headline News

Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 32 mins ago
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), EGRX: 13.50 (unch)

Upgrade Alert for ICU Medical (ICUI)
Comtex SmarTrend(R) - Tue Nov 11, 6:59AM CST
ICU Medical (NASDAQ:ICUI) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $71.81 on volume of 194,000 shares, above average daily volume of 126,000. ICU Medical share prices have moved between a 52-week high of $85.00 and a 52-week low of $35.58 and closed yesterday at 102% above that low price at $71.81 per share. The 200-day and 50-day moving averages have moved 0.16% higher and 0.83% higher over the past week, respectively.
ICUI: 82.16 (+10.35)

ICU Medical posts 3Q profit
Automated Insights - Tue Nov 11, 4:11AM CST
SAN CLEMENTE, Calif. (AP) _ ICU Medical Inc. (ICUI) on Tuesday reported profit of $6.4 million in its third quarter.
ICUI: 82.16 (+10.35)

ICU Medical's (ICUI) CEO Vivek Jain on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 6:51PM CST

ICUI: 82.16 (+10.35)

ICU Medical beats by $0.18, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:32PM CST

ICUI: 82.16 (+10.35)

ICU Medical (ICUI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST

ICUI: 82.16 (+10.35)

ICU Medical, Inc. Announces Third Quarter 2014 Results
GlobeNewswire - Mon Nov 10, 3:11PM CST
ICU Medical, Inc., (Nasdaq:ICUI) ("ICU Medical"

, a leader in innovative medical devices used in vascular therapy, oncology and critical care applications, today announced financial results for the third quarter and nine months ended September 30, 2014.
ICUI: 82.16 (+10.35)

Walgreens Hits the Rock with Court's Ruling on CFO Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:30PM CST
The controversy surrounding an inflated fiscal 2016 earnings forecast continues for leading drugstore chain Walgreen Co. (WAG).
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), WAG: 67.61 (-0.17)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST

HK: 2.89 (-0.36), WWD: 48.11 (-3.70), LLNW: 2.66 (+0.16), FXEN: 2.71 (-0.14), RMTI: 11.17 (+0.27), CZR: 11.18 (-0.36), EGY: 6.82 (-0.17), ICUI: 82.16 (+10.35), ICEL: 7.53 (-0.17), SAAS: 9.16 (+0.19), DMD: 5.73 (-1.40), NPSP: 29.26 (+2.35), SCLN: 8.14 (+0.04), ATHX: 1.51 (-0.03), CMLS: 3.11 (-0.18), TC: 2.16 (+0.20), ATW: 36.28 (-1.48), CLUB: 6.07 (-0.70), RAX: 42.25 (+4.93), PTLA: 27.50 (-0.15), IPAR: 29.08 (-0.14), ATLS: 37.00 (+0.13), AMBC: 24.38 (+1.01), CUI: 8.50 (+0.08), PDLI: 8.10 (+0.17), OMER: 18.58 (+1.09), PRAA: 61.69 (-2.16), CARA: 8.55 (-0.20), HALO: 8.83 (-0.49), MODN: 10.63 (+0.53), CALL: 8.68 (-1.81), ASEI: 48.50 (-7.59), HGR: 20.88 (+0.29), ERII: 4.41 (-0.57)

BioScrip (BIOS) Q3 Loss Wider than Expected, Revenues Top - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:10PM CST
BioScrip, Inc. (BIOS) recently declared its third-quarter 2014 results.
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), BIOS: 5.70 (+0.11)

Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), OMCL: 31.93 (-0.56)

Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), HSP: 56.72 (+0.74)

Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), SPHS: 2.70 (-0.05)

Rockwell Medical (RMTI) Worth Watching: Stock Surges 21.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, as the company saw its shares surge over 21% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), RMTI: 11.17 (+0.27)

CVS Health Beats Q3 Earnings, Revenues; Narrows Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:00PM CST
CVS Health Corporation (CVS) ??? formerly known as CVS Caremark ??? reported third-quarter 2014 adjusted earnings per share (EPS) of $1.15.
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), CVS: 89.90 (+0.71)

Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.44 (-0.01), ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), HAE: 36.89 (+0.23)

14.1% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Tue Nov 04, 11:13AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 14.13% as of today's recent price of $70.99.
ICUI: 82.16 (+10.35)

Cardiovascular Systems (CSII) Jumps: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:46AM CST
Cardiovascular Systems (CSII) was a big mover last session, with shares rising over 6% on the day.
ICUI: 82.16 (+10.35), CSII: 29.85 (-0.17), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60)

Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:25AM CST
AtriCure (ATRC) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 82.16 (+10.35), ABAX: 53.37 (+0.43), GWPH: 74.55 (+0.60), ATRC: 17.76 (+0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Indico Breach May Expose Thousands to Identity Theft

Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...

Zepp Health's Q2 2026 Results: Growth Amid Struggles

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Acer's New Monitors: ePaper, Triple Displays & More

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Volato Group Faces Merger Scrutiny Amid SOAR Deal

Unraveling the Volato Merger Drama Boy, the plot thickens with Volato Group, Inc. (SOAR), and it ain’t the first time we’ve seen this kind of shuffle in the market. Now, Volato’s got itself tangled up with Alignment Engine Inc. through a proposed merger. Sounds routine at first; we all know mergers are part of the corporate game. But here's the twist—shareholders...

Kareem's Lebanese Kitchen: A Culinary Tribute to Maryland

Embracing Tradition with a Modern Twist Well, here's to new beginnings wrapped in old flavors, folks. September 1, 2026, marks the arrival of Kareem's Lebanese Kitchen at Rio Lakefront in Gaithersburg, Maryland. It's where the Mediterranean meets the Chesapeake in an unexpected culinary celebration. Chef Rachid Eido's Legacy Third-generation Lebanese Chef Rachid Eido is...

RealityMine Appoints CPO Amidst Strong Growth Momentum

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Kroger's Strategic Shift: Ibbotson's Bold New Charge

Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...

Innventure Faces Class Action Over Alleged Deception

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...